PHARMAC just promised to fund Pre-Exposure Prophylaxis (PrEP) in order to halt new HIV infections in New Zealand.
The local ASO is happy as hell. And they want everyone to know they intend on NZ being the first country to pay for its citizens HIV prevention pill, Truvada for PrEP™, publicly.
In an article on their site, NZAF says:
“PHARMAC funding would maximise the potential benefit of PrEP in New Zealand,” says Jason Myers, Executive Director, New Zealand AIDS Foundation (NZAF).
“Making this tool publicly available would be a giant leap forward towards our ambitious goal of ending new HIV transmissions in New Zealand by 2025.”